☆Octagon Capital Advisors LP
Quality Q
0.672
AUM ($M)
1,090
Positions
26
Turnover
0.21
Top-10 wt
80%
Herfindahl
0.086
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 33 positions · portfolio value $1,090M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | TRIM | — | 16.5% | -1.6% | 179.5 | 1,841,667 | -105,000 | 5 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | ADD | — | 12.7% | +7.6% | 138.8 | 2,950,000 | +510,000 | 2 | — |
| ☆ABVX funds › | ABIVAX SA | ADD | — | 12.1% | +3.8% | 132.3 | 993,000 | +316,000 | 5 | — |
| ☆COGT funds › | COGENT BIOSCIENCES INC | HOLD | — | 8.3% | -1.7% | 90.9 | 2,350,000 | +0 | 5 | — |
| ☆ALMS funds › | ALUMIS INC | HOLD | — | 7.3% | +0.4% | 79.7 | 2,830,700 | +0 | 3 | — |
| ☆AVBP funds › | ARRIVENT BIOPHARMA INC | HOLD | — | 6.3% | +1.3% | 68.5 | 1,971,054 | +0 | 5 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | ADD | — | 6.1% | +1.7% | 66.0 | 9,693,244 | +833,333 | 5 | — |
| ☆BIOA funds › | BIOAGE LABS INC | HOLD | — | 3.9% | +0.5% | 42.8 | 1,748,000 | +0 | 3 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | HOLD | — | 3.6% | +0.2% | 39.7 | 338,900 | +0 | 2 | — |
| ☆KYMR funds › | KYMERA THERAPEUTICS INC | TRIM | — | 3.3% | -0.7% | 35.5 | 310,000 | -115,000 | 5 | — |
| ☆AKTS funds › | AKTIS ONCOLOGY INC | HOLD | — | 2.8% | +0.9% | 31.0 | 960,847 | +0 | 2 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 2.7% | -0.4% | 29.6 | 490,000 | +0 | 2 | — |
| ☆PALI funds › | PALISADE BIO INC | HOLD | — | 2.0% | -0.0% | 21.5 | 10,276,317 | +0 | 3 | — |
| ☆OCUL funds › | OCULAR THERAPEUTIX INC | TRIM | — | 1.9% | -1.1% | 20.4 | 2,075,000 | -1,091,600 | 5 | — |
| ☆IRON funds › | DISC MEDICINE INC | HOLD | — | 1.8% | -0.1% | 19.7 | 270,000 | +0 | 2 | — |
| ☆SMMT funds › | SUMMIT THERAPEUTICS INC | NEW | — | 1.7% | +1.7% | 18.2 | 1,250,000 | +1,250,000 | 1 | — |
| ☆PHVS funds › | PHARVARIS N V | ADD | — | 1.4% | +0.9% | 15.8 | 456,721 | +291,721 | 5 | — |
| ☆ANL funds › | ADLAI NORTYE LTD | NEW | — | 1.0% | +1.0% | 10.7 | 934,716 | +934,716 | 1 | — |
| ☆DTIL funds › | PRECISION BIOSCIENCES INC | TRIM | — | 1.0% | -0.4% | 10.6 | 1,350,000 | -886,732 | 3 | — |
| ☆DBVT funds › | DBV TECHNOLOGIES S A | HOLD | — | 0.9% | -0.5% | 9.4 | 574,200 | +0 | 5 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | NEW | — | 0.8% | +0.8% | 9.0 | 361,010 | +361,010 | 1 | — |
| ☆GYRE funds › | GYRE THERAPEUTICS INC | NEW | — | 0.6% | +0.6% | 6.3 | 954,416 | +954,416 | 1 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | TRIM | — | 0.5% | -1.4% | 5.9 | 315,000 | -1,170,000 | 5 | — |
| ☆UNCY funds › | UNICYCIVE THERAPEUTICS INC | HOLD | — | 0.4% | -0.3% | 4.7 | 1,000,000 | +0 | 5 | — |
| ☆CNTX funds › | CONTEXT THERAPEUTICS INC | TRIM | — | 0.2% | -1.4% | 1.7 | 3,050,000 | -2,200,000 | 2 | — |
| ☆GOSS funds › | GOSSAMER BIO INC | HOLD | — | 0.1% | -0.2% | 1.3 | 7,750,000 | +0 | 5 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -719,000 | 0 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS PLC | EXIT | — | 0.0% | -3.3% | 0.0 | 0 | -750,000 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -3.2% | 0.0 | 0 | -1,450,000 | 0 | — |
| ☆LXEO funds › | LEXEO THERAPEUTICS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -1,100,000 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -3.1% | 0.0 | 0 | -530,000 | 0 | — |
| ☆CATX funds › | PERSPECTIVE THERAPEUTICS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -791,555 | 0 | — |
| ☆EVMN funds › | EVOMMUNE INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -143,472 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,090 | 26 | 0.21 | 80% | 0.086 | 0.671 | — | in |
| 2026Q1 | 904 | 29 | 0.33 | 69% | 0.073 | 0.324 | — | in |
| 2025Q4 | 799 | 26 | 0.25 | 69% | 0.066 | 0.411 | — | in |
| 2025Q3 | 641 | 26 | 0.32 | 73% | 0.081 | 0.284 | — | in |
| 2025Q2 | 456 | 30 | 0.56 | 61% | 0.051 | 0.029 | — | entered |
| 2025Q1 | 508 | 33 | 0.00 | 59% | 0.049 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status